Increasing drugs costs puts 'huge pressure' on Manx Care finances

Healthcare provider currently forecasting a £15.2m overspend

Increased spend on drugs over the winter months poses a 'huge pressure' to Manx Care's finances.

That's according to the healthcare provider's finance director who provided an update on the organisation's finances at the most recent board meeting.

Earlier this year Manx Care was forecasting an overspend in excess of £18m but its most recent figures show that now stands at £15.2m.

Jackie Lawless says medication is one area that can see rising demand and therefore higher costs at this time of year: